Trial record 3 of 5 for:    Neuralstem

Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Neuralstem Inc. Identifier:
First received: April 28, 2011
Last updated: September 23, 2014
Last verified: May 2013